David J. Adelstein
大卫·阿德尔斯坦
MD
Professor of Medicine, Head and Neck Oncology头颈部肿瘤学教授
👥Biography 个人简介
David Adelstein is a pioneering medical oncologist who has spent four decades defining concurrent chemoradiotherapy regimens for head and neck cancer. His landmark RTOG trials established cisplatin-based chemoradiation as the foundation of organ-preservation strategies for laryngeal and oropharyngeal cancers.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Concurrent Chemoradiation
Established cisplatin plus radiation as the standard organ-preserving approach for advanced laryngeal and hypopharyngeal cancers through landmark RTOG trials.
Laryngeal Preservation
Demonstrated that concurrent chemoradiation is superior to induction chemotherapy followed by radiation for larynx preservation, shaping international guidelines.
Representative Works 代表性著作
An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients with Unresectable Squamous Cell Head and Neck Cancer
Journal of Clinical Oncology (2003)
Definitive trial demonstrating OS benefit of concurrent cisplatin-radiation over radiation alone in unresectable HNSCC.
Concurrent versus Sequential Chemoradiotherapy for Resectable Oropharyngeal Carcinoma
Journal of Clinical Oncology (2010)
Established sequencing principles that inform modern oropharyngeal cancer treatment protocols.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Robert L. Ferris
University of Pittsburgh Medical Center
Maura L. Gillison
MD Anderson Cancer Center
Kevin J. Harrington
Royal Marsden NHS Foundation Trust / Institute of Cancer Research
Jean-Louis Lefebvre
Centre Oscar Lambret
关注 大卫·阿德尔斯坦 的研究动态
Follow David J. Adelstein's research updates
留下邮箱，当我们发布与 David J. Adelstein（Cleveland Clinic Taussig Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment